StockpollyBeta
Get App
Popularity #4,118
NYXH · NASDAQ · Medical - Specialties

Nyxoah (NYXH)

Commercializes a leadless, battery-free therapy for obstructive sleep apnea.

$1.40
After-hours close0.00 (0.00%)
At close$1.40(−5.41%)

In millions of USD, except per-share figures · converted from EUR at the latest rate

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue121111122689
Cost of revenue011010011264
Gross profit111111111435
131415161822242429253029
Research & development81089913101215121011
557799141214142018
General & administrative55779914121414018
Other expenses0−10000000−100
Operating income−13−12−14−15−17−21−24−23−28−21−27−24
1001−24−2−10−57−14
Interest income111111110001
Interest expense0000121110215
Other non-operating income−20−1−11−310−15−8−1
Income before tax−11−13−13−15−19−17−25−23−27−26−21−37
Income tax expense−300102000111
Net income from continuing operations−9−12−14−15−20−20−26−24−27−27−21−38
Net income−9−12−14−15−20−20−26−24−27−27−21−38
EPS, basic−$0.31−$0.43−$0.48−$0.49−$0.57−$0.53−$0.69−$0.63−$0.72−$0.67−$0.42−$0.66
EPS, diluted−$0.31−$0.43−$0.48−$0.49−$0.57−$0.53−$0.69−$0.63−$0.72−$0.67−$0.42−$0.66
Weighted average shares, basic292929313437373737404357
Weighted average shares, diluted292929313437373737404357
EBITDA−10−12−12−13−18−17−24−22−25−25−17−22
Depreciation & amortization111101002220
EBIT−11−13−13−14−19−18−25−22−27−26−19−22